166 related articles for article (PubMed ID: 34561551)
1. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
Chiang S; Vasudevaraja V; Serrano J; Stewart CJR; Oliva E; Momeni-Boroujeni A; Jungbluth AA; Da Cruz Paula A; da Silva EM; Weigelt B; Park KJ; Soslow RA; Murali R; Ellenson LH; Benayed R; Ladanyi M; Abu-Rustum NR; Dickson MA; Cohen S; Aghajanian C; Hensley ML; Lee CH; Snuderl M; Konner JA
Mod Pathol; 2022 Jan; 35(1):117-127. PubMed ID: 34561551
[TBL] [Abstract][Full Text] [Related]
2. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract][Full Text] [Related]
4. p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH
Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176
[TBL] [Abstract][Full Text] [Related]
5. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
Alkanat NE; Uner A; Usubutun A
Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
[No Abstract] [Full Text] [Related]
6. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.
Dessources K; Miller KM; Kertowidjojo E; Da Cruz Paula A; Zou Y; Selenica P; da Silva EM; Benayed R; Ashley CW; Abu-Rustum NR; Dogan S; Soslow RA; Hensley ML; Weigelt B; Chiang S
Mod Pathol; 2022 Jul; 35(7):972-978. PubMed ID: 34961764
[TBL] [Abstract][Full Text] [Related]
7. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
8. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
12. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract][Full Text] [Related]
13. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities.
Zou Y; Turashvili G; Soslow RA; Park KJ; Croce S; McCluggage WG; Stewart CJR; Oda Y; Oliva E; Young RH; Da Cruz Paula A; Dessources K; Ashley CW; Hensley ML; Yip S; Weigelt B; Benayed R; Antonescu CR; Lee CH; Chiang S
Mod Pathol; 2020 Sep; 33(9):1861-1870. PubMed ID: 32317704
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.
Kommoss FKF; Stichel D; Schrimpf D; Kriegsmann M; Tessier-Cloutier B; Talhouk A; McAlpine JN; Chang KTE; Sturm D; Pfister SM; Romero-Pérez L; Kirchner T; Grünewald TGP; Buslei R; Sinn HP; Mechtersheimer G; Schirmacher P; Schmidt D; Lehr HA; Sahm F; Huntsman DG; Gilks CB; Kommoss F; von Deimling A; Koelsche C
J Cancer Res Clin Oncol; 2020 Jan; 146(1):97-104. PubMed ID: 31768620
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.
Huang HY; Ladanyi M; Soslow RA
Am J Surg Pathol; 2004 Feb; 28(2):224-32. PubMed ID: 15043312
[TBL] [Abstract][Full Text] [Related]
17. Endometrial stromal sarcoma: a clinicopathological analysis of 14 cases.
Wang F; Lei R; Yang H; Guo M; Tan G
Int J Clin Exp Pathol; 2018; 11(5):2799-2804. PubMed ID: 31938398
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
19. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
[TBL] [Abstract][Full Text] [Related]
20. Endometrial stromal neoplasms of the uterus. A clinicopathologic study.
Sieiński W
Patol Pol; 1992; 43(1):30-4. PubMed ID: 1296171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
